Literature DB >> 17877034

Follow-up of tibialis posterior transfer surgery (TPT) for drop-foot in leprosy.

Yutaka Ishida1, Saw Lwin, Kyaw Myint.   

Abstract

Prevention of Disability (POD) service needs to be expanded for future reducing the leprosy burden. Tibialis Posterior Transfer Surgery (TPT) is an established procedure and relatively easy to do at district level general hospitals. It can protect further damages of affected foot and consequently reduce patient's social burden as well. Totally 70 TPT surgeries were done during a joint project of JICA on leprosy control and basic health service in Myanmar for training purpose (Jan/2002-Jan/2006). A follow-up assessment was done for exploring the effectiveness of foot drop surgery, in Nov/2006 at 9-selected townships in Mid-Myanmar. 33 cases (Male 22, Female 11) were reviewed and the mean of follow up period was 29.1 months (SD=7.1, 10-48 months). Total results were; good: 25 cases (76%), fair: 4 cases (12%) and poor: 4 cases (12%). In good and fair cases, patients were satisfied with the results and TPT improved the QOL of patients. In almost all cases (32/33, 97%) after TPT, patients are free from plantar ulcer. Most serious complication of operation (4 cases, 12%) identified was inversion deformity due to loosed tension of lateral tail of grafted TP tendon sutured to Extensor Digitorum Longus. From the results of TPT surgery follow-up, it can benefit much to the patients if resources permit to make it as a routine service in more places.

Entities:  

Mesh:

Year:  2007        PMID: 17877034     DOI: 10.5025/hansen.76.219

Source DB:  PubMed          Journal:  Nihon Hansenbyo Gakkai Zasshi        ISSN: 1342-3681


  1 in total

1.  CORRELATION BETWEEN QUALITY OF LIFE AND THE CLINICAL RESULTS OF PATIENTS WITH LEPROSY WITH DROP FOOT AFTER TENDON TRANSFER.

Authors:  Jose Carlos Cohen; Natália Coelho Rodrigues; Elifaz de Freitas Cabral; Silvana Teixeira de Miranda; Antonio José Ledo Alves da Cunha; Maria Katia Gomes
Journal:  Acta Ortop Bras       Date:  2022-05-23       Impact factor: 0.683

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.